Age (years) | 65 (61–74) |
Male patients | 41 (59%) |
BMI (kg/m2) | 25.3 (22.0–32.3) |
Comorbidities | |
 Chronic respiratory disease | 30 (43%) |
 Chronic cardiac disease | 11 (16%) |
 Chronic kidney disease | 8 (11%) |
 Diabetes | 12 (17%) |
SAPS II | 43 (35–45) |
pH | 7.28 (7.22–7.32) |
PaCO2 (mmHg) | 64 (56–73) |
VT (ml/kg PBW) | 6.2 (5.9–7.9) |
Respiratory setting | |
 IMV | 59 (84%) |
 NIV | 11 (16%) |
Concomitant treatments | |
 Vasopressors | 27 (39%) |
 Renal replacement therapy | 8 (11%) |
 Neuromuscular blockade | 37 (53%) |
 Steroids | 16 (23%) |
 Prone positioning | 4 (6%) |